Enveda Therapeutics, Inc.

Biotechnology company · Boulder, Colorado, United States

Enveda Therapeutics, Inc. is a biotechnology company headquartered in Boulder, Colorado, United States. Its earliest recorded incorporation is in 2019. It has reported private securities offerings to the US SEC, most recently $62 million sold in a notice filed in 2023.

Profile compiled from public records. Is this your company? Request a correction or update

Enveda Therapeutics at a glance

Typebiotechnology company
HeadquartersBoulder, Colorado, United States
Earliest incorporation on record2019
SEC CIK1821392

What does Enveda Therapeutics do?

Private fundraising reported to the SEC

1 Form D notice; the most recent reported $62.5 million sold (2023).

Frequently asked questions about Enveda Therapeutics

Where is Enveda Therapeutics headquartered?

Enveda Therapeutics, Inc. is headquartered in Boulder, Colorado, United States.

What does Enveda Therapeutics do?

Enveda Therapeutics, Inc. is a biotechnology company.

When was Enveda Therapeutics founded?

The earliest incorporation on record for Enveda Therapeutics, Inc. is in 2019, according to public company registers.

Similar companies

Need a CRO or CDMO for your next study?

Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.

Compare quotes

Last updated 2026-09-23. Data licences